The interplay between Tregs, exhausted CD8+ T cells, and TAMs fosters an immunosuppressive TME, facilitating HCC development and progression A hallmark of HBV-HCC is the development of immune dysfunction, which significantly contributes to tumor progression. The gene discussed is CD8A; the disease is hepatocellular carcinoma.